Tyra Biosciences CEO Todd Harris' 2023 pay jumps 102% to $4.6M
Tyra Biosciences reports 2023 executive compensation
By ExecPay News
Published: April 18, 2024
Tyra Biosciences reported fiscal year 2023 executive compensation information on April 18, 2024.
In 2023, three executives at Tyra Biosciences received on average a compensation package of $3.5M, a 64% increase compared to previous year.
Todd Harris, Chief Executive Officer, received $4.6M in total, which increased by 102% compared to 2022. 77% of Harris' compensation, or $3.6M, was in option awards. Harris also received $456K in non-equity incentive plan, $608K in salary, as well as $950 in other compensation.
Alan Fuhrman, Chief Financial Officer, received a compensation package of $3.5M. 78% of the compensation package, or $2.8M, was in option awards.
Hiroomi Tada, Chief Medical Officer, earned $2.4M in 2023, a 90% increase compared to previous year.